Skip to main content

Table 4 Mortality associated with infection site and pathogen

From: The therapeutic efficacy of adjunct therapeutic plasma exchange for septic shock with multiple organ failure: a single-center experience

 

Overall

TPE

No TPE

p

Site of infection

 Pneumonia

26/40 (65%)

11/23 (47.8%)

15/17 (88.2%)

0.017

 GU

2/14 (14.3%)

0/6 (0%)

2/8 (25%)

 

 GI/biliary

6/12 (50%)

2/6 (33.3%)

4/6 (66.7%)

 

 Skin/soft tissue

1/5 (20%)

1/1 (100%)

0/4 (0%)

 

 Endocarditis

2/4 (50%)

1/3 (33.3%)

1/1 (100%)

 

 Primary bacteremia

5/5 (100%)

1/1 (100%)

4/4 (100%)

 

Organism cultured

 MRSA

2/5 (40%)

1/3 (33.3%)

1/2 (50%)

 

 Streptococcus

3/5 (60%)

1/2 (50%)

2/3 (66.7%)

 

 E. coli

6/11 (54.5%)

2/5 (40%)

4/6 (66.7%)

 

 Pseudomonas

2/2 (100%)

1/1 (100%)

1/1 (100%)

 

 Enterococcus

1/2 (50%)

0/1 (0%)

1/1 (100%)

 

 Enterobacter

3/8 (37.5%)

2/3 (66.7%)

1/5 (20%)

 

 Klebsiella

2/6 (33.3%)

0/4 (0%)

2/2 (100%)

 

 Influenza

2/3 (66.7%)

0/1 (0%)

2/2 (100%)

 

 Serratia

1/1 (100%)

1/1 (100%)

n/a

 

 C. difficile

1/2 (50%)

n/a

1/2 (50%)

 

 Salmonella

0/1 (0%)

n/a

0/1 (0%)

 

 Culture negative

3/14 (21.4%)

1/10 (10%)

2/4 (50%)

 

 Polymicrobial

16/20 (80%)

7/9 (77.8%)

9/11 (81.8%)

 
  1. *Pathogens in polymicrobial infections are not specified in the numbers above